From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Does Estrogen/Progestin Therapy Improve Quality of Life?

Older postmenopausal women without menopausal symptoms showed no improvements in quality of life after 3 years of continuous E/P therapy.

Initially published data from the Women's Health Initiative indicated that postmenopausal women who used continuous combined estrogen/progestin (E/P) therapy experienced significantly greater increases in certain adverse outcomes (i.e., coronary events, stroke, venous thrombosis, and breast cancer) than did placebo recipients (Journal Watch Jul 26 2002). Investigators now have examined the data to determine whether any improvement in quality of life had occurred among E/P users.

A total of 16,608 women (age range, 50-79) with intact uteri were assigned to receive 0.625-mg conjugated equine estrogens plus 2.5-mg medroxyprogesterone acetate or matched placebos daily. Quality-of-life measures (including estimates of general health, vitality, mental health, depressive symptoms, and sexual satisfaction) were collected at baseline and at 1 year for all women and also at 3 years for a subset of 1511 women. At 1 year, users of E/P had a small, but statistically significant, benefit in terms of sleep disturbances, physical functioning, and pain; however, at 3 years, no benefit was noted for any measure. In younger women (age range, 50-54), E/P improved vasomotor symptoms and sleep disturbances at 1 year, but no other benefits were detected.

Comment: An editorialist notes that this analysis provides further evidence for withholding estrogen therapy from all asymptomatic postmenopausal women. These findings suggest that hormone therapy does not improve quality of life among older women without menopausal symptoms, but some of the measurement instruments could have missed small benefits. For some younger symptomatic women, short-term E/P therapy might make the transition to the postmenopausal years tolerable.

— Robert W. Rebar, MD

Published in Journal Watch General Medicine May 9, 2003

Citation(s):

Hays J et al. Effects of estrogen plus progestin on health-related quality of life. N Engl J Med 2003 May 8; 348:1839-54.

Grady D. Postmenopausal hormones -- Therapy for symptoms only. N Engl J Med 2003 May 8; 348:1835-7.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2003. Massachusetts Medical Society. All rights reserved.